Prospective Study of the Influence of the Diffuse Noxious Inhibitory Controls of the Pain on the Efficacy of Milnacipran in Fibromyalgia Therapy
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Milnacipran (Primary)
- Indications Fibromyalgia; Musculoskeletal pain
- Focus Therapeutic Use
- 08 Jul 2014 Biomarkers information updated
- 11 Jan 2013 New trial record